Premium
US-headquartered private equity giant The Carlyle Group appears likely to score modest returns from the sale of a little more than half its stake in pathology chain operator Metropolis Healthcare Ltd’s initial public offering (IPO) next week. The Mumbai-based diagnostics chain has set a price band of Rs 877-880 per share ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
